Search results

From WikiAnesthesia
  • Rocuronium (category Neuromuscular blockers)
    Butterworth IV, John F.; Mackey, David C.; Wasnick, John D. (2022), "Neuromuscular Blocking Agents", Morgan & Mikhail’s Clinical Anesthesiology (7 ed.), New
    2 KB (86 words) - 13:27, 22 December 2022
  • Vecuronium (category Neuromuscular blockers)
    clinical practice Lien, Cynthia A.; Eikermann, Matthias (2013), "Neuromuscular Blockers and Reversal Drugs", Pharmacology and Physiology for Anesthesia
    5 KB (420 words) - 08:10, 5 January 2023
  • Succinylcholine (category Neuromuscular blockers)
    Succinylcholine, also known as suxamethonium, is a short-acting neuromuscular blocker used during intubation. hyperkalemia increased risk of malignant
    2 KB (25 words) - 15:41, 17 July 2022
  • Mivacurium (category Neuromuscular blockers)
    in the United States of America Goodwin, G., Joseph, V. (2015). Neuromuscular Blockers. In: Kaye, A., Kaye, A., Urman, R. (eds) Essentials of Pharmacology
    6 KB (503 words) - 08:28, 5 January 2023
  • Cisatracurium (category Neuromuscular blockers)
    retrieved 2023-01-05 Lien, Cynthia A.; Eikermann, Matthias (2013), "Neuromuscular Blockers and Reversal Drugs", Pharmacology and Physiology for Anesthesia
    5 KB (449 words) - 13:14, 8 January 2023
  • Brachial plexus blocks Interscalene block Supraclavicular block Infraclavicular block Axillary block Digital block Wrist block Intercostal nerve block Pectoralis
    48 KB (3,891 words) - 15:30, 27 June 2024
  • to nondepolarizing neuromuscular blockers Resistant to succinylcholine At increased risk for developing phase II neuromuscular block, particularly with
    6 KB (544 words) - 03:57, 17 July 2022
  • disease may incite hyperkalemia after administration Non-depolarizing neuromuscular blockers may be prolonged Take caution with regional anesthesia, although
    3 KB (171 words) - 04:51, 14 June 2023
  • In those patients who are heterozygous for Asp70Gly, the effects of neuromuscular blockade may be prolonged three to eight times that of normal3. In those
    18 KB (2,664 words) - 18:49, 4 October 2022
  • Sugammadex (category Neuromuscular blocker reversal agents)
    Sugammadex Sugammadex is used to reverse neuromuscular blockade from rocuronium and vecuronium. If a patient requires reparaylsis after administration
    3 KB (161 words) - 23:34, 29 March 2022
  • reaction, not anaphylaxis Allergic reactions are more likely from neuromuscular blockers than antibiotics From Vaisman, et al. JAMA 2017 Patients at increased
    10 KB (1,348 words) - 10:29, 1 September 2023
  • preferred for rapid emergence to facilitate early neuro exam. Patient neuromuscularly blocked throughout to reduce risk of inadvertent injury. No neuromonitoring
    4 KB (82 words) - 16:59, 31 July 2022
  • Used to revere the effects of neuromuscular blocking agents. Neostigmine reverses the effects of neuromuscular blocking agents by inhibiting acetylcholinesterase
    26 KB (3,311 words) - 10:02, 27 June 2024
  • Neuromuscular blockade involves the use of neuromuscular blocking agents (NMBAs) (i.e. paralytics) to facilitate endotracheal intubation and/or surgical
    8 KB (1,025 words) - 03:45, 4 July 2022
  • Clinical data Drug class Neuromuscular blocker Routes of administration Intravenous Dosage Pharmacodynamics Mechanism of action Nicotinic acetylcholine
    1 KB (9 words) - 23:32, 29 March 2022
  • Clinical data Drug class Neuromuscular blocker Dosage Pharmacodynamics Mechanism of action Nicotinic acetylcholine antagonism Pharmacokinetics Physical
    1 KB (9 words) - 23:33, 29 March 2022
  • (low albumin level), and increased sensitivity. Non depolarizing neuromuscular blocking agents should be chosen with patients organ function in mind. Often
    24 KB (969 words) - 16:42, 19 August 2024
  • ketamine, or dexmedetomidine with a longer acting nondepolarizing neuromuscular blocker infusion. Tend to avoid propofol due to risk of interfering with
    7 KB (731 words) - 11:21, 4 May 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)